274 related articles for article (PubMed ID: 32920591)
1. Celastrol Inhibits Migration and Invasion of Triple-Negative Breast Cancer Cells by Suppressing Interleukin-6 via Downregulating Nuclear Factor-κB (NF-κB).
Yan F; Wu Z; Li Z; Liu L
Med Sci Monit; 2020 Sep; 26():e922814. PubMed ID: 32920591
[TBL] [Abstract][Full Text] [Related]
2. Sinomenine inhibits breast cancer cell invasion and migration by suppressing NF-κB activation mediated by IL-4/miR-324-5p/CUEDC2 axis.
Song L; Liu D; Zhao Y; He J; Kang H; Dai Z; Wang X; Zhang S; Zan Y
Biochem Biophys Res Commun; 2015 Aug; 464(3):705-10. PubMed ID: 26166821
[TBL] [Abstract][Full Text] [Related]
3. Celastrol inhibits lipopolysaccharide-induced angiogenesis by suppressing TLR4-triggered nuclear factor-kappa B activation.
Ni H; Zhao W; Kong X; Li H; Ouyang J
Acta Haematol; 2014; 131(2):102-11. PubMed ID: 24157922
[TBL] [Abstract][Full Text] [Related]
4. Activation of GPER suppresses migration and angiogenesis of triple negative breast cancer via inhibition of NF-κB/IL-6 signals.
Liang S; Chen Z; Jiang G; Zhou Y; Liu Q; Su Q; Wei W; Du J; Wang H
Cancer Lett; 2017 Feb; 386():12-23. PubMed ID: 27836733
[TBL] [Abstract][Full Text] [Related]
5. miR-224 is critical for celastrol-induced inhibition of migration and invasion of hepatocellular carcinoma cells.
Li H; Li Y; Liu D; Sun H; Liu J
Cell Physiol Biochem; 2013; 32(2):448-58. PubMed ID: 23988648
[TBL] [Abstract][Full Text] [Related]
6. Celastrol inhibits breast cancer cell invasion via suppression of NF-ĸB-mediated matrix metalloproteinase-9 expression.
Kim Y; Kang H; Jang SW; Ko J
Cell Physiol Biochem; 2011; 28(2):175-84. PubMed ID: 21865725
[TBL] [Abstract][Full Text] [Related]
7. Celastrol inhibits interleukin-17A-stimulated rheumatoid fibroblast-like synoviocyte migration and invasion through suppression of NF-κB-mediated matrix metalloproteinase-9 expression.
Li GQ; Zhang Y; Liu D; Qian YY; Zhang H; Guo SY; Sunagawa M; Hisamitsu T; Liu YQ
Int Immunopharmacol; 2012 Dec; 14(4):422-31. PubMed ID: 22954486
[TBL] [Abstract][Full Text] [Related]
8. Receptor-interacting protein kinase 2 promotes triple-negative breast cancer cell migration and invasion via activation of nuclear factor-kappaB and c-Jun N-terminal kinase pathways.
Singel SM; Batten K; Cornelius C; Jia G; Fasciani G; Barron SL; Wright WE; Shay JW
Breast Cancer Res; 2014 Mar; 16(2):R28. PubMed ID: 24642040
[TBL] [Abstract][Full Text] [Related]
9. Celastrol Inhibits the Proliferation and Induces Apoptosis of Colorectal Cancer Cells via Downregulating NF-κB/COX-2 Signaling Pathways.
Zhang H; Zhao X; Shang F; Sun H; Zheng X; Zhu J
Anticancer Agents Med Chem; 2022; 22(10):1921-1932. PubMed ID: 34732120
[TBL] [Abstract][Full Text] [Related]
10. [Effect of lupeol on migration and invasion of human breast cancer MDA-MB-231 cells and its mechanism].
Wang M; Cui HX; Sun C; Li G; Wang HL; Xia CH; Wang YC; Liu JC
Yao Xue Xue Bao; 2016 Apr; 51(4):558-62. PubMed ID: 29859524
[TBL] [Abstract][Full Text] [Related]
11. Icariin-induced inhibition of SIRT6/NF-κB triggers redox mediated apoptosis and enhances anti-tumor immunity in triple-negative breast cancer.
Song L; Chen X; Mi L; Liu C; Zhu S; Yang T; Luo X; Zhang Q; Lu H; Liang X
Cancer Sci; 2020 Nov; 111(11):4242-4256. PubMed ID: 32926492
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA NKILA inhibited angiogenesis of breast cancer through NF-κB/IL-6 signaling pathway.
Luo LH; Rao L; Luo LF; Chen K; Ran RZ; Liu XL
Microvasc Res; 2020 May; 129():103968. PubMed ID: 31862380
[TBL] [Abstract][Full Text] [Related]
13. Astragaloside IV inhibits migration and invasion in human lung cancer A549 cells via regulating PKC-α-ERK1/2-NF-κB pathway.
Cheng X; Gu J; Zhang M; Yuan J; Zhao B; Jiang J; Jia X
Int Immunopharmacol; 2014 Nov; 23(1):304-13. PubMed ID: 25218161
[TBL] [Abstract][Full Text] [Related]
14. Celastrol blocks interleukin-6 gene expression via downregulation of NF-κB in prostate carcinoma cells.
Chiang KC; Tsui KH; Chung LC; Yeh CN; Chen WT; Chang PL; Juang HH
PLoS One; 2014; 9(3):e93151. PubMed ID: 24664372
[TBL] [Abstract][Full Text] [Related]
15. Celastrol, a novel triterpene, potentiates TNF-induced apoptosis and suppresses invasion of tumor cells by inhibiting NF-kappaB-regulated gene products and TAK1-mediated NF-kappaB activation.
Sethi G; Ahn KS; Pandey MK; Aggarwal BB
Blood; 2007 Apr; 109(7):2727-35. PubMed ID: 17110449
[TBL] [Abstract][Full Text] [Related]
16. Puerarin suppresses LPS-induced breast cancer cell migration, invasion and adhesion by blockage NF-κB and Erk pathway.
Liu X; Zhao W; Wang W; Lin S; Yang L
Biomed Pharmacother; 2017 Aug; 92():429-436. PubMed ID: 28558356
[TBL] [Abstract][Full Text] [Related]
17. Nitro-fatty acid inhibition of triple-negative breast cancer cell viability, migration, invasion, and tumor growth.
Woodcock CC; Huang Y; Woodcock SR; Salvatore SR; Singh B; Golin-Bisello F; Davidson NE; Neumann CA; Freeman BA; Wendell SG
J Biol Chem; 2018 Jan; 293(4):1120-1137. PubMed ID: 29158255
[TBL] [Abstract][Full Text] [Related]
18. Celastrol inhibits the migration and invasion and enhances the anti-cancer effects of docetaxel in human triple-negative breast cancer cells.
Liu Z; Fan M; Xuan X; Xia C; Huang G; Ma L
Med Oncol; 2022 Sep; 39(12):189. PubMed ID: 36071249
[TBL] [Abstract][Full Text] [Related]
19. miR-29b-3p promotes progression of MDA-MB-231 triple-negative breast cancer cells through downregulating TRAF3.
Zhang B; Shetti D; Fan C; Wei K
Biol Res; 2019 Jul; 52(1):38. PubMed ID: 31349873
[TBL] [Abstract][Full Text] [Related]
20. The apatinib inhibits breast cancer cell line MDA-MB-231 in vitro by inducing apoptosis, cell cycle arrest, and regulating nuclear factor-κB (NF-κB) and mitogen-activated protein kinase (MAPK) signaling pathways.
Maroufi NF; Vahedian V; Akbarzadeh M; Mohammadian M; Zahedi M; Isazadeh A; Pouremamali F; Taefehshokr S; Heidari M; Rashidi M; Nouri M
Breast Cancer; 2020 Jul; 27(4):613-620. PubMed ID: 32026267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]